vTv Therapeutics Inc. Gains 53.44%
Mon, Mar 17, 2025 at 07:41 PM
vTv Therapeutics Inc. (VTVT:NASDAQ) rocketted at $22.74, a gain of 53.4%. On Mon, Mar 17, 2025, VTVT:NASDAQ touched a New 2-Week High of $22.74. The stock got featured on our News Catalysts scanner on Mon, Mar 17, 2025 at 12:50 PM in the 'BIOTECH' category. From Mon, Mar 03, 2025, the stock recorded 30.00% Up Days and 18.18% Green Days
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 195.08%
- AirNet Technology Inc. (ANTE:NASDAQ), 97.93%
- Scienture Holdings Inc Com (SCNX:NASDAQ), 66.44%
- Monogram Orthopaedics Inc. (MGRM:NASDAQ), 57.51%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 56.93%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 53.44%
- SES AI Corporation Class A (SES:NYSE), 49.57%
- Quantum Biopharma Ltd. (QNTM:NASDAQ), 46.83%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 46.59%